Migalastat Capsules are indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data.
The grants will support organizations in Phoenix working to increase equitable access to health care, address social determinants of health and educate the community on the effects of air pollution.